Who is sponsoring NCT03205839?

NCT03205839 is sponsored by University of Sheffield.

What drugs are being tested in NCT03205839?

Interventions in NCT03205839: Acceptance-based self-help intervention.

What condition does NCT03205839 study?

NCT03205839 studies Visible Difference, Acceptance and Commitment Therapy, ACT, Skin Condition, Hair Condition, Craniofacial, Burns.

Is NCT03205839 still recruiting?

NCT03205839 is currently completed. Last updated 19 June 2018.

Last reviewed 2018-06-19 · How we verify

NCT03205839

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acceptance-based Self-help for Individuals With Visible Difference and Social Anxiety

Completed NA Last updated 19 June 2018

What this trial tests

NA trial testing Acceptance-based self-help intervention in Visible Difference in 284 participants. Completed in 1 June 2018.

Timeline

27 July 2017

Primary endpoint
18 November 2017

1 June 2018

Quick facts

Lead sponsor	University of Sheffield
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	284
Start date	27 July 2017
Primary completion	18 November 2017
Estimated completion	1 June 2018
Sites	1 location across United Kingdom

Drugs / interventions tested

Acceptance-based self-help intervention

Conditions studied

Visible Difference — all drugs for Visible Difference →
Acceptance and Commitment Therapy — all drugs for Acceptance and Commitment Therapy →
ACT — all drugs for ACT →
Skin Condition — all drugs for Skin Condition →

Sponsor

University of Sheffield

Who can join

18 and older, any sex, with Visible Difference or Acceptance and Commitment Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The acceptance and commitment therapy (ACT) model theoretically fits with treating appearance-related anxiety in individuals with a visible difference. This study examines the effectiveness of an acceptance-based self-help manual for this population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Sheffield trials

Trials by the same sponsor.

NCT07049042 — Hypogonadotrophic Hypogonadism in Genetic Neurodevelopmental Conditions · recruiting
NCT07132879 — Telehealth in MND-Research (TIM-R): A Research Database for MND · recruiting
NCT06628427 — Unlock the Secrets of Ageing Brains Through P300 Brain-computer Interface Games · not yet recruiting
NCT06476483 — Feasibility and Acceptability of Implementing DIALOG+ in a Psychiatric Rehabilitation Unit · NA · completed
NCT06508840 — The Clear Conversations Project · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03205839 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Sheffield
Last refreshed: 19 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03205839.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing